FDA Issues Draft Guidance on Tentatively Approved ANDAs

Drug Industry Daily
A A
The FDA released draft guidance Wednesday for companies seeking amendments or final approval for tentatively approved ANDAs — the first guidance to emerge during the partial government shutdown.

To View This Article:

Login

Subscribe To Drug Industry Daily